OCEA Stock Summary and Trading Ideas (Ocean Biomedical | NASDAQ:OCEA)

Ocean Biomedical Inc is a biopharmaceutical company that is focused on discovering and developing therapeutic products in oncology, fibrosis, and infectious diseases. The company is developing an antibody therapeutic product candidate inhibiting Chi3l1, and a bi-specific antibody product candidate inhibiting Chi3l1 plus PD-1 and CTLA-4 for the treatment of non-small cell lung cancer and glioblastoma multiforme; and a small molecule product candidate targeting Chit1 for the treatment of Idiopathic Pulmonary Fibrosis and Hermansky-Pudlak Syndrome.

Ocean Biomedical trades on the NASDAQ stock market under the symbol OCEA.

As of February 21, 2025, OCEA stock price declined to $0.13 with 13,857,847 million shares trading.

OCEA has a market cap of $16.73 million. This is considered a Sub-Micro Cap stock.

The top ETF exchange traded funds that OCEA belongs to (by Net Assets): VTI, VXF, IWC.

OCEA has underperformed the market in the last year with a price return of -77.2% while the SPY ETF gained +22.1%. OCEA has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -82.2% and -4.7%, respectively, while the SPY returned +1.4% and -0.1%, respectively.

OCEA support price is $.12 and resistance is $.16 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that OCEA shares will trade within this expected range on the day.